Position in EOLS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$104,100
+$42,450 QoQ
Shares Held
15,000
0.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 158 holders
Holding Since
Jun 2020
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Derivatives in EOLS
reported options exposure · as of Jun 30, 2020CallValue
$38,690
CallShares
7,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026OneDigital Investment Advisors LLC holds $3,435,973 across 9 Drug Manufacturers - Specialty & Generic names. EOLS ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
103,434 | $1,642,531 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
3,493 | $588,710 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
573 | $310,468 | |
| 4 | ZTS |
Zoetis Inc.
|
3,106 | $223,197 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
8,709 | $214,328 | |
| 6 | HLN |
Haleon plc
|
22,327 | $208,310 | |
| 7 | TRLV |
Trulieve Cannabis Corp.
|
11,779 | $115,787 | |
| 8 | EOLS |
Evolus, Inc.
This page
|
15,000 | $104,100 |
All Filings in EOLS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $104,100 | 15,000 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $61,650 | 15,000 | Shares | Sole | 2026-05-08 | |
| 2020-06-30 | $37,158 | 7,011 | Shares | Sole | 2020-08-14 | |
| 2020-06-30 | $38,690 | 7,300 | Call | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||